Wallington Asset Management’s Elevance Health ELV Stock Holding History

Wallington Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-506	Closed	-$263K	–	96
2024 Q3	$263K	Buy	506 +106	+27%	+$56.6K	0.04%	84
2024 Q2	$217K	Hold	400	–	–	0.03%	79
2024 Q1	$207K	Buy	+400	New	+$199K	0.03%	79
2023 Q1	–	Sell	-400	Closed	-$205K	–	83
2022 Q4	$205K	Buy	+400	New	+$203K	0.04%	73
2022 Q2	–	Sell	-428	Closed	-$210K	–	86
2022 Q1	$210K	Buy	+428	New	+$196K	0.04%	67
2021 Q3	–	Sell	-594	Closed	-$227K	–	79
2021 Q2	$227K	Hold	594	–	–	0.04%	63
2021 Q1	$213K	Buy	+594	New	+$191K	0.04%	67
2019 Q2	–	Sell	-2,292	Closed	-$658K	–	57
2019 Q1	$658K	Buy	+2,292	New	+$663K	0.17%	45

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wallington Asset Management's ELV Position: Q4 2024 in Review

Wallington Asset Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 506 shares — an estimated $263K sold.

Wallington Asset Management first reported a position in ELV in Q1 2019 and held it in 8 quarters. The position peaked at $658K in Q1 2019. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Wallington Asset Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Wallington Asset Management sold 506 Elevance Health shares in Q4 2024, an estimated $263K.
Wallington Asset Management first reported a position in Elevance Health in Q1 2019 and held it in 8 quarters.
Wallington Asset Management's Elevance Health position peaked at $658K in Q1 2019.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Wallington Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.